Multiple cellular enzymes and signaling proteins

The term Multiple cellular enzymes and signaling proteins is a non-specific descriptor rather than a single, defined therapeutic target. It is frequently used in pharmacological literature and drug labeling to describe the broad-spectrum activity of agents that interact with a wide array of intracellular components, such as multi-kinase inhibitors or non-specific cytotoxic agents (FDA, 2023). Because this designation aggregates numerous distinct biological entities, it does not refer to a unique protein, receptor, or gene product that can be characterized by a single canonical name or structure (IUPHAR/BPS Guide to Pharmacology, 2024). In the context of drug discovery, such broad targeting is often associated with polypharmacology, which may provide clinical benefits in complex diseases like cancer but also carries a high risk of off-target toxicity and adverse side effects (Nature Reviews Drug Discovery, 2018). Consequently, this entry is considered incorrect or overly broad for structured target identification, as it lacks the specificity required for modern precision medicine and rational drug design.

Other names

Multi-targetNon-specific cellular proteinsIntracellular signaling network

Non-specific modulation or inhibition of various intracellular proteins and enzymatic pathways.